Literature DB >> 24834637

Decompression of peripheral nerve trunks in leprosy prevents the development and progression of deformities?

S Husain.   

Abstract

Peripheral nerve involvement results in deformities formation in leprosy. High doses of (40-60 mg) steroids along with the anti-leprosy drugs is preferred even though the 70-75% cases develop deformity with the above treatment. 772 ulnar nerves, 120 median nerves and 108 posterior tibial nerves not responding to above medical treatment in 12 weeks, were undertaken for external and internal nerve trunk decompression. These cases were followed-up for 5-20 years at various intervals. The pain in nerves (neuritis) recovered in all cases of ulnar, median and posterior tibial nerves. Full sensory recovery with pin prick/feather or cotton wool touch was seen in 50% cases of all the three nerves. 20% cases maintain the pre-operative levels of sensory status. Plantar ulcers healed within 6 months after decompression of posterior tibial nerve. Only 6 cases showed reoccurrence. Overall motor recovery in ulnar nerve was seen 89% and 70% in median nerve. The sensory recovery restores protective sensation which prevents secondary injuries. The improvement of motor power gave better functional hands and improved the appearance which in absence of surgical intervention was not possible.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24834637

Source DB:  PubMed          Journal:  Indian J Lepr        ISSN: 0254-9395


  2 in total

1.  Epineurotomy for leprous, high ulnar neuropathy: defining a safe corridor based on the epineural vascular anatomy.

Authors:  Anil Dhal; Yasim Khan; Sumit Arora
Journal:  Int Orthop       Date:  2021-05-24       Impact factor: 3.075

2.  Endoneural abscess of common popliteal nerve as first clinical manifestation of leprosy: the first reported case in history in a low-incidence country.

Authors:  A Balestrino; N Riccardi; P Fiaschi; P Anania; C Martinoli; S Gennaro
Journal:  J Prev Med Hyg       Date:  2020-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.